Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α
暂无分享,去创建一个
Takla Griss | E. E. Vincent | B. Faubert | Russell G. Jones | R. Shaw | D. Shackelford | R. Svensson | B. Samborska | D. Avizonis | O. Mamer | S. Izreig | E. Vincent | Said Izreig
[1] D. Hardie,et al. LKB1 and AMPK and the cancer-metabolism link - ten years after , 2013, BMC Biology.
[2] Liu Wei,et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. , 2013, Cancer cell.
[3] Takla Griss,et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. , 2013, Cell metabolism.
[4] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[5] Brian Keith,et al. HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.
[6] Christian M. Metallo,et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.
[7] W. Marston Linehan,et al. Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.
[8] Jesse M. Platt,et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability , 2011, Proceedings of the National Academy of Sciences.
[9] G. Semenza. Oxygen sensing, homeostasis, and disease. , 2011, The New England journal of medicine.
[10] W. H. Schaefer,et al. Metabolic profiles show specific mitochondrial toxicities in vitro in myotube cells , 2011, Journal of biomolecular NMR.
[11] G. Semenza. Regulation of metabolism by hypoxia-inducible factor 1. , 2011, Cold Spring Harbor symposia on quantitative biology.
[12] G. Semenza. mechanisms of disease Oxygen Sensing , Homeostasis , and Disease , 2011 .
[13] J. Yokota,et al. Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. , 2010, Lung cancer.
[14] David Carling,et al. Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation , 2010, Science.
[15] D. Sgroi,et al. Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis , 2010, Proceedings of the National Academy of Sciences.
[16] D. Nicholls,et al. Neuronal Glutamate and Gabaa Receptor Function in Health and Disease Spare Respiratory Capacity, Oxidative Stress and Excitotoxicity Glutamate as an Excitotoxin the Role of Oxidative Stress , 2022 .
[17] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[18] Chin-Lee Wu,et al. mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome , 2009, Proceedings of the National Academy of Sciences.
[19] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[20] Kwok-Kin Wong,et al. Somatic LKB1 Mutations Promote Cervical Cancer Progression , 2009, PloS one.
[21] Russell G. Jones,et al. Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.
[22] R. Shaw. LKB1: cancer, polarity, metabolism, and now fertility. , 2008, The Biochemical journal.
[23] D. Hayes,et al. Role of LKB1 in lung cancer development , 2008, British Journal of Cancer.
[24] Ralph J Deberardinis,et al. Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.
[25] Kwok-Kin Wong,et al. Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas. , 2008, Cancer research.
[26] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[27] D. Neil Hayes,et al. LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.
[28] R. Deberardinis,et al. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. , 2007, Genes & development.
[29] T. Mak,et al. Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era? , 2007, Science's STKE.
[30] S. Gruber,et al. Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome , 2006, Clinical Cancer Research.
[31] N. Denko,et al. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.
[32] G. Semenza,et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.
[33] Daniel E Bauer,et al. ATP citrate lyase inhibition can suppress tumor cell growth. , 2005, Cancer cell.
[34] P. Schumacker,et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. , 2005, Cell metabolism.
[35] P. Schumacker,et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. , 2005, Cell metabolism.
[36] Massimo Zeviani,et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. , 2005, Cell metabolism.
[37] Russell G. Jones,et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.
[38] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[39] R. DePinho,et al. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. , 2004, Genes & development.
[40] William R Sellers,et al. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. , 2003, Cancer cell.
[41] G. Sapkota,et al. LKB1, a protein kinase regulating cell proliferation and polarity , 2003, FEBS letters.
[42] W. Sellers,et al. TSC 2 regulates VEGF through mTOR-dependent and-independent pathways , 2003 .
[43] David Sidransky,et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. , 2002, Cancer research.
[44] A. Harris,et al. Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival , 2001, British Journal of Cancer.
[45] L. Aaltonen,et al. LKB1 somatic mutations in sporadic tumors. , 1999, The American journal of pathology.
[46] M. Stratton,et al. A serine/threonine kinase gene defective in Peutz–Jeghers syndrome , 1998, Nature.
[47] J. Folch,et al. Preparation of lipide extracts from brain tissue. , 1951, The Journal of biological chemistry.